BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32315625)

  • 21. Molecular mechanism and physiological role of active-deactive transition of mitochondrial complex I.
    Babot M; Galkin A
    Biochem Soc Trans; 2013 Oct; 41(5):1325-30. PubMed ID: 24059527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triton X-100 as a specific inhibitor of the mammalian NADH-ubiquinone oxidoreductase (Complex I).
    Ushakova AV; Grivennikova VG; Ohnishi T; Vinogradov AD
    Biochim Biophys Acta; 1999 Jan; 1409(3):143-53. PubMed ID: 9878712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of Synthetic Ubiquinone QT Catalyzed by Bovine Mitochondrial Complex I Is Decoupled from Proton Translocation.
    Okuda K; Murai M; Aburaya S; Aoki W; Miyoshi H
    Biochemistry; 2016 Jan; 55(3):470-81. PubMed ID: 26701224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allosteric nucleotide-binding site in the mitochondrial NADH:ubiquinone oxidoreductase (respiratory complex I).
    Grivennikova VG; Gladyshev GV; Vinogradov AD
    FEBS Lett; 2011 Jul; 585(14):2212-6. PubMed ID: 21624365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversible, electrochemical interconversion of NADH and NAD+ by the catalytic (Ilambda) subcomplex of mitochondrial NADH:ubiquinone oxidoreductase (complex I).
    Zu Y; Shannon RJ; Hirst J
    J Am Chem Soc; 2003 May; 125(20):6020-1. PubMed ID: 12785808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Superoxide is produced by the reduced flavin in mitochondrial complex I: a single, unified mechanism that applies during both forward and reverse electron transfer.
    Pryde KR; Hirst J
    J Biol Chem; 2011 May; 286(20):18056-65. PubMed ID: 21393237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mitochondrial complex I: progress in understanding of catalytic properties.
    Vinogradov AD; Grivennikova VG
    IUBMB Life; 2001; 52(3-5):129-34. PubMed ID: 11798024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bovine heart NADH-ubiquinone oxidoreductase contains one molecule of ubiquinone with ten isoprene units as one of the cofactors.
    Shinzawa-Itoh K; Seiyama J; Terada H; Nakatsubo R; Naoki K; Nakashima Y; Yoshikawa S
    Biochemistry; 2010 Jan; 49(3):487-92. PubMed ID: 19961238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges in elucidating structure and mechanism of proton pumping NADH:ubiquinone oxidoreductase (complex I).
    Zickermann V; Dröse S; Tocilescu MA; Zwicker K; Kerscher S; Brandt U
    J Bioenerg Biomembr; 2008 Oct; 40(5):475-83. PubMed ID: 18982432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ischemic A/D transition of mitochondrial complex I and its role in ROS generation.
    Dröse S; Stepanova A; Galkin A
    Biochim Biophys Acta; 2016 Jul; 1857(7):946-57. PubMed ID: 26777588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The deactive form of respiratory complex I from mammalian mitochondria is a Na+/H+ antiporter.
    Roberts PG; Hirst J
    J Biol Chem; 2012 Oct; 287(41):34743-51. PubMed ID: 22854968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transhydrogenation reactions catalyzed by mitochondrial NADH-ubiquinone oxidoreductase (Complex I).
    Yakovlev G; Hirst J
    Biochemistry; 2007 Dec; 46(49):14250-8. PubMed ID: 18001142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EPR characterization of ubisemiquinones and iron-sulfur cluster N2, central components of the energy coupling in the NADH-ubiquinone oxidoreductase (complex I) in situ.
    Magnitsky S; Toulokhonova L; Yano T; Sled VD; Hägerhäll C; Grivennikova VG; Burbaev DS; Vinogradov AD; Ohnishi T
    J Bioenerg Biomembr; 2002 Jun; 34(3):193-208. PubMed ID: 12171069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Steady-state kinetics of the reduction of coenzyme Q analogs by complex I (NADH:ubiquinone oxidoreductase) in bovine heart mitochondria and submitochondrial particles.
    Fato R; Estornell E; Di Bernardo S; Pallotti F; Parenti Castelli G; Lenaz G
    Biochemistry; 1996 Feb; 35(8):2705-16. PubMed ID: 8611577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Q-site inhibitor induced ROS production of mitochondrial complex II is attenuated by TCA cycle dicarboxylates.
    Siebels I; Dröse S
    Biochim Biophys Acta; 2013 Oct; 1827(10):1156-64. PubMed ID: 23800966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A competitive inhibition of the mitochondrial NADH-ubiquinone oxidoreductase (complex I) by ADP-ribose.
    Zharova TV; Vinogradov AD
    Biochim Biophys Acta; 1997 Jul; 1320(3):256-64. PubMed ID: 9230920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions between phospholipids and NADH:ubiquinone oxidoreductase (complex I) from bovine mitochondria.
    Sharpley MS; Shannon RJ; Draghi F; Hirst J
    Biochemistry; 2006 Jan; 45(1):241-8. PubMed ID: 16388600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. -->H+/2e- stoichiometry in NADH-quinone reductase reactions catalyzed by bovine heart submitochondrial particles.
    Galkin AS; Grivennikova VG; Vinogradov AD
    FEBS Lett; 1999 May; 451(2):157-61. PubMed ID: 10371157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton pumping by complex I (NADH:ubiquinone oxidoreductase) from Yarrowia lipolytica reconstituted into proteoliposomes.
    Dröse S; Galkin A; Brandt U
    Biochim Biophys Acta; 2005 Dec; 1710(2-3):87-95. PubMed ID: 16289468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the proton-translocating NADH:ubiquinone oxidoreductases of mitochondria and Escherichia coli using the inhibitor 1,10-phenanthroline.
    Finel M; Majander A
    FEBS Lett; 1994 Feb; 339(1-2):142-6. PubMed ID: 8313963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.